These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 29793447
1. B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients. Xie H, Zhu Y, Zhang J, Liu Z, Fu H, Cao Y, Li G, Shen Y, Dai B, Xu J, Ye D. BMC Cancer; 2018 May 24; 18(1):590. PubMed ID: 29793447 [Abstract] [Full Text] [Related]
2. Prognostic and Predictive Value of O6-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer. Zhang J, Zhu Y, Wang Y, Fu Q, Xie H, Liu Z, Fu H, Cao Y, Xu J, Dai B. Ann Surg Oncol; 2018 Jan 24; 25(1):342-348. PubMed ID: 29116491 [Abstract] [Full Text] [Related]
3. Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer. Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Xie H, Fu Q, Dai B, Ye D, Xu J. Clin Cancer Res; 2018 Jul 01; 24(13):3069-3078. PubMed ID: 29514839 [Abstract] [Full Text] [Related]
4. Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma. Xie H, Zhu Y, An H, Wang H, Zhu Y, Fu H, Wang Z, Fu Q, Xu J, Ye D. Oncotarget; 2016 May 31; 7(22):32723-30. PubMed ID: 27092876 [Abstract] [Full Text] [Related]
5. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses. Zeng H, Liu Z, Wang Z, Zhou Q, Qi Y, Chen Y, Chen L, Zhang P, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, Dai B, Guo J, Xu L, Zhang W, Xu J. Int J Cancer; 2020 Jan 15; 146(2):542-552. PubMed ID: 31584197 [Abstract] [Full Text] [Related]
6. Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance? Labban M, Najdi J, Mukherji D, Abou-Kheir W, Tabbarah A, El-Hajj A. Cancer Rep (Hoboken); 2021 Apr 15; 4(2):e1313. PubMed ID: 33538412 [Abstract] [Full Text] [Related]
7. SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancer. Keck B, Wach S, Goebell PJ, Kunath F, Bertz S, Lehmann J, Stöckle M, Taubert H, Wullich B, Hartmann A. Ann Surg Oncol; 2013 Oct 15; 20(11):3669-74. PubMed ID: 23807662 [Abstract] [Full Text] [Related]
13. High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy. Burgess EF, Livasy C, Trufan S, Hartman A, Guerreri R, Naso C, Clark PE, Grigg C, Symanowski J, Raghavan D. Urol Oncol; 2019 Dec 15; 37(12):900-906. PubMed ID: 31597600 [Abstract] [Full Text] [Related]
14. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy. Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Kitayam M, Hirota K. Urol Oncol; 2014 Aug 15; 32(6):820-5. PubMed ID: 24951323 [Abstract] [Full Text] [Related]